Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer
Abstract
Uterine cervical cancer is one of the leading causes of cancer-related mortality in women worldwide. Each year, over half a million new cases are estimated, resulting in more than 300,000 deaths. While less-invasive, fertility-preserving surgical procedures can be offered to women in early stages, treatment for locally advanced disease may include radical hysterectomy, primary chemoradiotherapy (CRT) or a combination of these modalities....
Paper Details
Title
Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer
Published Date
Nov 17, 2021
Journal
Volume
13
Issue
22
Pages
5748 - 5748
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History